Skip to main content

Pharmacokinetics and Interactions of Ciclosporin

  • Conference paper
Ciclosporin in Autoimmune Diseases

Abstract

Ciclosporin (CyA) is a potent immunosuppressive agent which acts selectively upon the immune response by inhibition of the lymphokine cascade, thus inhibiting cell-cell communication [1]. In addition, augmentation of the inflammatory response is attenuated by blockade of macrophage migration inhibition factor (MIF) and macrophage arming factor (MAF), limiting the delayed-type hypersensitivity response and immunologically nonspecific tissue injury [2]. By virtue of its efficacy and immunologic specificity, CyA is employed extensively in organ transplantation, and also appears to be of major potential importance in the area of auto-immunity.

Supported in part by grants from the Medical Research Council of Canada, the Ivey Foundation, and the Kidney Foundation of Canada

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bunjes, Hardic D, Rollinghoff M, Wagner H (1981) Cyclosporin A Mediates Immunosuppression of Primary Cytotoxic T-Cell Responses by Impairing the Release of Interleukin 1 and Interleukin 2. Eur J Immunol 11:657–661

    Article  PubMed  CAS  Google Scholar 

  2. Thompson AW, Moon DK, Geczy CL, Nelson DS (1983) Cyclosporin A Inhibits Lymphokine Production but not the Responses of Macrophages to Lymphokines. Immunology 48:291–299

    Google Scholar 

  3. Beveridge T, Gratwohl A, Michot F et al. (1981) Cyclosporin A: Pharmacokinetics after a Single Dose in Man and Serum Levels after Multiple Dosing in Recipients of Allogeneic Bone-Marrow Grafts. Current Therapeutic Research 30:5–18

    Google Scholar 

  4. Keown PA, Stiller CR, Ulan RA et al. (1981) Immunological and Pharmacological Monitoring in the Clinical Use of Cyclosporin A. Lancet 1:686–689

    Article  PubMed  CAS  Google Scholar 

  5. Lemaire M, Tillement JP (1982) Role of Lipoproteins and Erythrocytes in the In Vitro Binding and Distribution of Cyclosporin A in the Blood. J Pharm Pharmacol 34:715–718

    Article  PubMed  CAS  Google Scholar 

  6. Wall WJ, Keown PA, Stiller CR, McKenzie N, Devinini R, Stawecki M, McMichael J, Howson W, Muirhead N, Hollomby D (1984) Efficacy and Safety of Low Dose Continuous Intravenous Cyclosporine (CyA). Abstracts: 10th International Congress of The Transplantation Society, Minneapolis S 3.6, 61–62

    Google Scholar 

  7. Keown PA, Laupacis A, Carruthers G, Stawecki M, Koegler J, McKenzie FN, Wall W, Stiller CR (1984) Interaction between Phenytoin and Cyclosporine following Organ Transplantation. Transplantation, Vol 38, No 3, 304–306

    PubMed  CAS  Google Scholar 

  8. Ferguson RM, Sutherland DE, Simmons RL, Najarian JS (1982) Ketoconazole, Cyclosporin Metabolism, and Renal Transplantation ( Letter ). Lancet 2:882–3

    Google Scholar 

  9. Keown PA (1984) Cyclosporine Blood Level Monitoring. Transplantation Immunology Letter Supplement, Vol 1, No 2, November

    Google Scholar 

  10. Keown PA, Stiller CR, Laupacis AL et al. (1982) The Effects and Side-effects of Cyclosporine: Relationship to Drug Pharmacokinetics. Transplantation Proceedings 14:659–661

    PubMed  CAS  Google Scholar 

  11. Stiller CR, Dupre J, Gent M, Jenner MR, Keown PA, Laupacis A, Martell R, Rodger NW, Graffenried B, Wolfe BMJ (1984) Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset. Science 223:1362–1367

    Article  PubMed  CAS  Google Scholar 

  12. Petric R, Keown PA, Stiller CR, Wallace AC, McDonald JWD (1985) Affect of Cyclosporine (CyA) on Renal Function, Blood Flow, and Prostacyclin A and Thromboxane Generation in Experimental Animal Model. 1st International Meeting on Experimental Cyclosporine Nephrotoxicity, Basel, April (Abstract)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Sandoz Ltd, Basle

About this paper

Cite this paper

Keown, P.A., Stiller, C.R., Stawecki, M., McMichael, J., Howson, W. (1985). Pharmacokinetics and Interactions of Ciclosporin. In: Schindler, R. (eds) Ciclosporin in Autoimmune Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70607-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70607-3_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-70609-7

  • Online ISBN: 978-3-642-70607-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics